Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05306964 · ClinicalTrials.gov registry record · NA

Restrictive Versus Liberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney Injury

A NA study, sponsored by University of Pittsburgh.

Terminated
Registry status
NA
Development phase
99
Enrollment target

NCT05306964 is a NA study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 99 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05306964, a NA study, was terminated before completion, sponsored by University of Pittsburgh.

TERMINATED
Registry status
NA
Development phase
99 participants
Enrollment target

Study Summary

Critically ill patients with acute kidney injury and fluid overload who are frequently treated by fluid removal during dialysis are at an increased risk of complications and death. Both slower and faster rates of fluid removal may cause injury to the vital organs. This proposed clinical trial will examine the feasibility of restrictive compared with a liberal rate of fluid removal in order to develop effective treatments for fluid overload and to improve the health of critically ill patients.

Interventions

  • PROCEDURE Restrictive UFnet Rate Strategy
  • PROCEDURE Liberal UFnet Rate Strategy

Trial Details

FieldValue
Enrollment Target 99 participants
Start Date 2022-07-05
Est. Completion 2024-06-26
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT05306964

The ClinicalTrials.gov registry entry for NCT05306964 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Restrictive UFnet Rate Strategy is the first listed.

NCT05306964 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05306964 about?

NCT05306964 is a clinical study titled "Restrictive Versus Liberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney Injury". Critically ill patients with acute kidney injury and fluid overload who are frequently treated by fluid removal during dialysis are at an increased risk of complications and death. Both slower and faster rates of fluid removal may cause injury to the vital organs. This proposed clinical trial will e...

What is the current status of trial NCT05306964?

This trial is currently terminated. It is a NA study. The enrollment target is 99 participants. The study started on 2022-07-05. Estimated completion is 2024-06-26.

What interventions are being tested in trial NCT05306964?

The interventions under investigation include: Restrictive UFnet Rate Strategy (PROCEDURE), Liberal UFnet Rate Strategy (PROCEDURE).

Who is sponsoring clinical trial NCT05306964?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.